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Abstract
Agriculture is an indispensable part of every person’s life, ensuring that nutritious and inexpensive food is readily available.
As any other organisms, plants are subject to numerous parasitic infections. Biological evolution has allowed plants to produce
a variety of toxic compounds to deal with their pathogens. American pokeweed plant (Phytolacca americana) manufactures
pokeweed antiviral protein, a ribosome inactivating protein that disrupts protein synthesis and lowers infectivity of many
plant and animal viruses. The intricate mechanism of PAP antiviral activity entails a delicate coordination and interplay of
several factors, allowing the plant to battle its invaders. Here, we examine the molecular mechanism of this plant peptide, and
describe a molecular model of pokeweed’s antiviral activity.
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Introduction
Agriculture continues to be confronted by epidemics, having
devastating effects on economies and the plant sources essential for
human and animal life. Plants are essential for human and animal life,
and encompass natural and landscaped spaces, including forests, crops,
nurseries and orchards. Multitudes of microbial pathogens invade and
colonize plants, while metabolizing their tissues and disrupting a delicate
balance of hormones and nutrients, and in some cases, suppressing
gene activity [1-3]. Many plants have evolved to produce natural
defense mechanisms that aid in the battle with foreign pathogenic
invaders. Plant defense mechanisms include myriad physical and
chemical defenses, which prevent pathogens from entering the plant
cell, limit their availability, and/or restrict the nutrients necessary for
the growth and replication of the pathogen [4-8].

Ribosome Inactivating Proteins (RIPs)
Ribosome inactivating proteins (RIPs) are a group of cytotoxic
proteins possessing extremely specific rRNA N-glycosidase activity,
and proficient in catalytically inactivating ribosomes, inducing cellular
death [9]. The biological effects credited to these protein toxins go
back to early times, owing to the high toxicities of the castor bean and
jequirity bean [10]. Yet other plants, such as American pokeweed (P.
americana) and common soapwort, synthesize pokeweed antiviral
protein (PAP) and saporin, that impose lower toxicity on intact cells
while inhibiting protein production in cell-free lysates [11-13]. RIPs
exert their cytotoxicity by impairing ribosomes [14]; specifically they
interfere with the advanced stages of translation [15-19]. While all
RIPs exert N-glycosidase activity toward ribosomes, their substrate
specificity is greatly diversified. For instance, ricin exhibits vigorous
activity toward mammalian and yeast ribosomes while virtually
having no significant effect on bacterial or plant ribosomes [20-23];
PAP however is able to depurinate ribosomes from plants, bacteria,
yeast, as well as lower and higher animals [15,24-27]. Contribution of
the substrate specificity comes from both RIPs and ribosomes alike.
RIPs depurinate specific adenines within the sarcin/ricin loop of large
rRNA; this introduced lesion interferes with the advanced stages of
translation [15,28].
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Activities Attributed to PAP
In addition to ribosomal depurination, some RIPs act on naked rRNA
(rRNA devoid of ribosomal proteins); some remove multiple adenines
and guanines from various nucleic acid substrates including DNA,
poly(A), rRNA, and even viral RNA [29-32]. Viral RNA depurination
is a matter that is worthy of attention. Duggar and Armstrong [33]
have observed that a protein from P. americana possessed an antiviral
activity, and inhibited transmission of tobacco mosaic virus (TMV)
in plants; though, not until 1978 PAP was accepted as an inhibitor of
protein synthesis [25]. While the mechanism of PAP antiviral activity is
somewhat unclear, recent findings, produced by the Hudak and Tumer
laboratories, show that this activity is not dependent exclusively on
inactivation of ribosomes [34,35]. It has been postulated that a direct
interaction of PAP with viral RNA (or DNA) is an alternative antiviral
mechanism in play. The pokeweed plant produces several isozymes
of PAP, all exerting potent antiviral properties [11,13,36-42]. PAP
isozymes evoke depurination of genomic HIV-1 RNA [43-45], TMV
RNA [46], poliovirus [47], herpes simplex virus (HSV) [48], influenza
virus [49], and brome mosaic virus (BMV) [50], among many others,
showing a broad spectrum of antiviral activity [13]. This depurination
is concentration dependent.

PAP Inhibits Replication of Capped Viruses
Recent findings have put forward an interesting mechanism for
the translation inhibition by PAP [51], where PAP specifically targets
and depurinates capped mRNA directly. Hudak et al. [51] generated
several PAP mutations (PAPx, an active site mutant (E176V); PAPn, a
mutant with a substitution (G75D) in the N-terminal sequence; PAPc,
a mutant lacking the C-terminal 25 amino acid residues) and showed
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that these PAP mutants do not depurinate rabbit or tobacco ribosomes,
yet inhibit the in vitro translation of potato virus X and BMV with no
notable depurination of ribosomes. These studies showed that PAP
is proficient in differentiating capped from uncapped mRNAs, since
wild type (WT) PAP, and several of its mutants, prompted inhibition
of only capped (but not uncapped) luciferase transcripts. The presence
of cap analog decreased the ability of PAP and PAP mutants to inhibit
translation of viral RNA, meaning that these toxic proteins are able to
identify the cap structure at the 5ʹ end of the mRNA. Examination of the
PAP-treated luciferase transcripts reveled that only the capped RNAs
were subject to cleavage by acidic aniline, and hence were depurinated
in vitro. Based upon these important findings, it was concluded that
PAP binding to the cap structure, with subsequent RNA depurination,
was the main mechanism for the translation inhibition; depurination of
capped viral RNA perhaps, is the primary mechanism for the antiviral
activity of PAP [52]. Furthermore, Friedland team have examined
interactions between PAP and m7GTP cap analog employing direct
fluorescence titrations [53]; this led to quantitative characterization of
these interactions.

PAP Inhibits Replication of Uncapped Viruses
Although only less than twenty percent of plant positive strand
RNA viruses are similarly structured to host mRNA (with a 5ʹ-m7G cap
and poly(A) tail) [54], the majority lack one or both of these moieties.
Interestingly, PAP also exerts its inhibitory effects on the replication
uncapped viruses such as influenza and poliovirus [47,49]. Vivanco
et al. [55] have inspected PAP activity against a set of capped and
uncapped viral RNAs, demonstrating that PAP does not depurinate
every capped RNA, while inhibiting translation of uncapped viral
RNAs in vitro without causing measurable depurination at multiple
sites. PAP did not depurinate uncapped luciferase mRNA, while
depurinating TMV and BMV transcripts, demonstrating that PAP is

able to discriminate between capped and uncapped RNAs. No evident
depurination of capped alfalfa mosaic virus (AMV) RNA was recorded
either. This indicates that the recognition of the cap feature alone is not
enough to cause multiple site depurination of RNAs [55]. Furthermore,
the team did not record any evident depurination of uncapped satellite
panicum mosaic virus (SPMV) RNA, tomato bushy stunt virus (TBSV)
RNA, nor uncapped RNA encompassing a poliovirus internal ribosome
entry site (IRES); yet, in vitro translation experiments illustrated PAP
inhibiting translation of the above viral RNAs [55].

Interactions with Translation Initiation Factors (eIFs)
and Effects of Structured RNA
Work published by Wang and Hudak [56] presents confirmation
that PAP is able to bind eukaryotic translation initiation factor eIF4G
and its isoform eIFiso4G. Studies show that PAP binds specifically to
each form, and biochemical and genetic analyses present confirmation
that the region of the protein between amino acids 511 and 624 is
needed for PAP binding activity [56]. PAP binds to m7GTP-Sepharose;
this binding does not reduce the binding of PAP to purified eIFiso4G,
indicating that PAP simultaneously forms a complex with eIFiso4G
and the cap moiety. In wheat germ lysate translational system, PAP
depurinated uncapped transcripts containing a functional WT 3ʹ
translational enhancer element (3ʹ TE), but did not depurinate
messages containing a non-functional mutant 3ʹ TE [56]. These
findings supports a previously postulated hypothesis that binding of
PAP to eIF4G (or eIFiso4G) may offer an alternative mechanism for
PAP to access both uncapped and capped viral RNAs for depurination.
Baldwin et al. [53] have demonstrated that PAP not only binds to
the initiation factor eIFiso4G, but that binding of the cap analog to
PAP is amplified by this macromolecular interactions, supporting
previous findings. This suggests a novel mechanism: PAP interacts
with eIFiso4G/eIF4G (as part of eIFiso4F/eIF4F) and interacts with the

Figure 1: Schematic diagram of the proposed model for PAP interaction with initiation factors and capped (A) or uncapped (B) RNA. A) Step 1: PAP binds to 5ʹ-m7G
cap; eIF4G/eIFiso4G associates with PAP; eIF binding increases PAP-RNA affinity; Step 2: eIF4E/eIFiso4E or eIF4F/eIFiso4F displaces PAP from 5ʹ-m7G cap;
Step 3: PAP/eIF4G/eIFiso4G complex translocates to depurination sites; Step 4: PAP depurinates RNA. B) Step 1: PAP binds 5ʹ- or 3ʹ-UTRs (untranslated regions)
containing TEs (translational enhancer sequences), or IRES (internal ribosome entry site); Step 2: eIF4G/eIFiso4G or eIF4F/eIFiso4F bind to PAP or 5ʹ- and/or
3ʹ-UTRs, increasing PAP-RNA affinity; Step 3: PAP/eIF4G/eIFiso4G or PAP/eIF4F/eIFiso4F complex translocates to depurination sites; Step 4: PAP depurinates RNA.
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cap moiety of mRNA. Moreover, addition of eIFiso4E/eIF4E (as part
of eIFiso4F/eIF4F) competitively diminishes binding affinity of PAP
for the cap, since both proteins are cap-binding [53]. These PAP-eIF
interactions possibly unfold the active site of PAP, allowing PAP to
recognize target adenine residues for depurination (Figure 1A) [53].
Recent work performed in our laboratory showed that PAP binds to
and depurinates the 5ʹ-leader sequence from tobacco etch virus (TEV)
RNA [57]. The TEV 5ʹ-leader is sufficient to confer cap-independent
translation, even in the absence of the 5ʹ-terminal VPg (a viral genomelinked protein) [58,59]. The TEV 5ʹ-leader contains an IRES element
[58-60] that is notable for its small size, and represents one of the
most compact viral elements capable of promoting cap-independent
translation yet identified. A 5ʹ-proximal, 45-nt RNA pseudoknotencompassing domain (PK1) within the TEV 5ʹ-leader is essential to
promote cap-independent translation [61]. Mutations disrupting the
PK1 reduce cap-independent translation, including mutations to loop
3 that exhibit complementarity to a conserved region in eukaryotic
18S rRNA [61]. Furthermore, PAP bind to both full length TEV leader
sequence and the PK1, yet depurinates only the full length leader
element, indicating that PAP’s binding affinity is separate from its
depurinating activity [62]. Employing a pull-down assay, we showed
that PAP binds to eIFiso4G and eIFiso4E simultaneously, and this was
confirmed by fluorescence resonance energy transfer (FRET) [63].
These findings support a model, previously proposed by Wang and
Hudak [56]: the recognition and depurination of uncapped mRNA by
PAP is promoted by the translation initiation factors, allowing PAP to
gain access to uncapped, non-polyadenylated RNAs containing either
5ʹ- (and/or 3ʹ-) TEs, associating with eIF4F/eIFiso4F protein complexes
(Figure 1B).

Conclusion
The mechanism of PAP antiviral activity, specifically PAP
recognition of its substrate viral RNAs, is complex and entails the
interplay of a set of different factors. The initial recognition may occur
through PAP binding to the cap structure found at the 5ʹ-end of the
capped viral genomes, thereby enabling PAP to access its substrates for
depurination (Kd for PAP-m7GTP 43.3 ± 0.1 nM at 25°C) [53]. In the
instances where the 5ʹ-cap is absent, PAP directly binds to either the
5ʹ- or 3ʹ-UTRs (untranslated regions), containing either translational
enhancer sequences or an internal ribosome entry site (Kd for PAPuncapped full length TEV 5ʹ-leader RNA is 28.5 ± 3.7 nM; Kd for
PAP-m7GpppG-capped full length TEV 5ʹ-leader RNA is 87.5 ± 4.8
nM) [62]; binding of the eIFs increases PAP-RNA affinity, promoting
depurination of RNA (presence of eIFiso4G increases 2.4-fold PAP-cap
interactions) [53]. Additionally, PAP isoforms selectivity for different
ribosomes and RNAs varies (e.g., PAP-I, found in spring leaves of the
pokeweed plant, exhibits RC50 of 1.5 nM towards rat liver ribosomes
and 4.7 nM towards E. coli ribosomes [38]; PAP-S1, an isoform found
in seeds of the plant, exhibits IC50 of 3.2 nM towards rat liver ribosomes
and 280 nM towards E. coli ribosomes [41,42]; whereas α-PAP,
expressed in all organs of the plant, exhibits IC50 of 1.3 nM towards rat
liver ribosomes and 25 nM towards E. coli ribosomes [13,42]. In recent
years, a viral protein (VPg), linked to genome of turnip mosaic virus
(TuMV) was shown to inhibit PAP activity in vitro [13,57]. This viral
peptide serves as an analog of the 5ʹ-m7G cap of viral RNA, and has been
shown to play an important role in mRNA translation since it interacts
with the cap-binding proteins (e.g., eIF4E, eIFiso4E, eIF4F, eIFiso4F)
[64,65]. Our laboratory has shown that PAP interacts with VPg (Kd is
29.5 ± 1.8 nM) and inhibits PAP’s activity in a dose-dependent manner
[57], perhaps providing an evolutionary advantage for the virus to
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overcome this plant defense mechanism. A valid question to ask would
be: If PAP depurinates both ribosomal and viral RNA, how does the
pokeweed plant prevent its own death? Recent study shows that PAP is
able to form a homodimer complex in the cytosol of pokeweed plant,
while its monomeric form is predominantly found outside the cell, the
apoplast [66]. The PAP homodimer was shown to be much less active
on rRNA in comparison to the monomeric PAP. Hudak et al. have
shown that PAP dimerization involves an active site Tyr123; mutations
of this aromatic residue prevented dimerization of PAP in vivo,
supporting the biological role of homodimerization as a mechanism to
limit toxicity to cells synthesizing PAP [66].
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